GGrantIndex
Sort

39,280 grants matching leukemia

Project 3

$539,108
Branden S Moriarity · University Of Minnesota · P01 · FY2022 · CA

Live Tumor Culture Core and Tissue Specific Culture System for Human Cancers

$539,092
Tan A. Ince · Weill Medical Coll Of Cornell Univ · R33 · FY2020 · CA

(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia

$538,977
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Training Program in Molecular Hematology

$538,959
Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2016 · HL

CHANGING PARENTAL BELIEFS IN PEDIATRICS ONCOLOGY

$538,817
Children'S Hospital Of Philadelphia · R01 · FY2003 · CA

Targeting gasdermin D to treat myelodysplastic syndromes

$538,762
Peng Ji · Northwestern University At Chicago · R01 · FY2025 · HL

Targeting gasdermin D to treat myelodysplastic syndromes

$538,762
Peng Ji · Northwestern University At Chicago · R01 · FY2023 · HL

Elucidation of Human Natural Killer Cell Development

$538,711
Aharon G Freud · Ohio State University · R01 · FY2024 · CA

Tissue Core

$538,699
Laura Z Rassenti · University Of California, San Diego · P01 · FY2014 · CA

Targeting PIM-2 Kinase for Improving Cancer Immunotherapy

$538,665
Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2025 · CA

Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications

$538,547
Kelly Diringer Getz · University Of Pennsylvania · R01 · FY2022 · HL

Microbiota-focused strategies to mitigate GVHD

$538,525
Robert Jenq · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · HL

PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY

$538,465
University Of Virginia Charlottesville · R37 · FY2001 · AI

Molecular Pharmacology Lab

$538,464
Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA

Administrative Core

$538,428
Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2019 · CA

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

$538,425
Margaret Goodell · Baylor College Of Medicine · R01 · FY2015 · CA

The role of the cohesin complex in hematopoietic transformation and leukemia maintenance

$538,343
Aaron D Viny · Columbia University Health Sciences · R37 · FY2025 · CA

The role of heme in retinal vascular development and disease

$538,339
Thomas Darmody Arnold · University Of California, San Francisco · R01 · FY2023 · EY

Fate of Spermatogonial Stem Cells

$538,255
Georgetown University · R01 · FY2005 · HD

Targeted Therapies for Lymphoid Malignancies

$538,241
Jennifer A. Woyach · Ohio State University · R01 · FY2025 · CA

Targeted Therapies for Lymphoid Malignancies

$538,241
Jennifer A. Woyach · Ohio State University · R01 · FY2021 · CA

Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML

$538,185
Muxiang Zhou · Emory University · R01 · FY2025 · CA

A longitudinal assessment of frailty in young adult survivors of childhood cancer

$538,152
Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2017 · CA

Occupational Exposure Assessment

$538,124
Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

ONCOGENESIS AND MYELOID TRANSCRIPTION FACTORS IN AML

$538,074
Daniel G Tenen · Dana-Farber Cancer Inst · P01 · FY2010 · CA